AstraZeneca Covid-19 Vaccine Suspended across Europe. “Possible Autoimmune Reactions, Blood Clotting, Stroke and Internal bleeding”

Several European countries have now suspended the mRNA AstraZeneka Vaccine including Denmark, Norway, Iceland, Austria, Bulgaria. And more recently: Germany, Netherlands, Ireland, France, Italy, Estonia, Lithuania, Luxembourg and Romania. Thailand and the Democratic Republic of the Congo (DRC) have also suspended the AstraZeneka vaccine. 

On March 10, 2021, an open letter was submitted by a Collective of prominent medical doctors and scientists to the European Medicines Agency (EME):

Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns  By

Doctors for COVID Ethics, March 10, 2021

The letter (posted on Global Research) describes:

“serious potential consequences of COVID-19 vaccine technology, warning of possible autoimmune reactions, blood clotting abnormalities, stroke and internal bleeding, “including in the brain, spinal cord and heart”.

See also the Press Release issued by the Doctors for COVID Ethics

In recent developments (March 15, 2021), Germany’s Ministry of Health has confirmed the “temporary suspension” of the AstraZeneca COVID-19 vaccine: ,

“The European Medicines Agency is to  decide “whether and how the new information will affect the authorization of the vaccine” pending an investigation.  (Deutsche Welle).

The mRNA Vaccine

There are two other major pharmaceutical conglomerates, namely Pfizer and Moderna involved in marketing the mRNA vaccine technology, which is categorized in the US as an “experimental” drug.

Sofar the suspensions apply only to AstraZeneca.

In the US, the “Green Light” to market the experimental Pfizer-BioNTech mRNA vaccine was granted back in December 2020, despite the fact that according to the FDA, the vaccine is an “unapproved product”.

The FDA in its ambiguous statement has provided a so-called Emergency Use Authorization (EUA) to the Pfizer-BioNTech vaccine, namely “to permit the emergency use of the unapproved product, … for active immunization…” (see below)

 

***

By Prof Michel Chossudovsky
Published by Global Research

 

Republished by The 21st Century

The views expressed in this article are solely those of the author and do not necessarily reflect the opinions of 21cir.

 

Sharing is caring!

Leave a Reply